Digestive
OTC Healthcare > Digestive remedies

Digestive Remedies in Brazil

Brazil

Euromonitor International's Digestive Remedies in Brazil market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.

Tables: 54  |  Publication date: May 2009
Cost: 
GBP560.00

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Product coverage

Child-specific digestive remedies; Diarrhoeal remedies; IBS treatments; Indigestion and heartburn remedies; Laxatives; Motion sickness remedies

Table of contents

OTC HEALTHCARE IN BRAZIL : MARKET INSIGHT

EXECUTIVE SUMMARY

Positive economy indicators push sales of OTC healthcare

New rules for OTC advertising

Hypermarcas acquires DM Indústria Farmacêutica and Farmasa

Further consolidation of drugstores

Slowdown growth in the next two years

KEY TRENDS AND DEVELOPMENTS

Further restriction to advertising of OTC products

Hypermarcas acquires two leading OTC manufacturers

Specific department for OTC products established within ANVISA

Financial crisis affects OTC products

Senior consumers and women over 40 years old attract investment

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008

Table 2 Life Expectancy at Birth 2003-2008

MARKET DATA

Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008

Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008

Table 5 OTC Healthcare Company Shares by Value 2004-2008

Table 6 OTC Healthcare Brand Shares by Value 2005-2008

Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008

Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008

Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013

Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013

APPENDIX

OTC Registration and Classification

De-reimbursement

Advertising

Packaging and labelling

Distribution

Vitamins and Dietary Supplements Registration and Classification

Self-medication and Preventative Medicine

Generics

Switches

Summary 1 OTC Healthcare Switches 2005-2007

DEFINITIONS

Summary 2 Research Sources

LOCAL COMPANY PROFILES - BRAZIL

ACHé LABORATóRIOS FARMACêUTICOS SA - OTC HEALTHCARE - BRAZIL

STRATEGIC DIRECTION

KEY FACTS

Summary 3 Aché Laboratórios Farmacêuticos SA: Key Facts

Summary 4 Aché Laboratórios Farmacêuticos SA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 5 Aché Laboratórios Farmacêuticos SA: Production Statistics 2007

COMPETITIVE POSITIONING

Summary 6 Aché Laboratórios Farmacêuticos SA: Competitive Position 2008

BAYER SA - OTC HEALTHCARE - BRAZIL

STRATEGIC DIRECTION

KEY FACTS

Summary 7 Bayer SA: Key Facts

Summary 8 Bayer SA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 9 Bayer SA: Competitive Position 2008

BOEHRINGER INGELHEIM DO BRASIL QUíMICA E FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL

STRATEGIC DIRECTION

KEY FACTS

Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts

Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 12 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2007

COMPETITIVE POSITIONING

Summary 13 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2008

DM INDúSTRIA FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL

STRATEGIC DIRECTION

KEY FACTS

Summary 14 DM Indústria Farmacêutica Ltda: Key Facts

Summary 15 DM Indústria Farmacêutica Ltda: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 16 DM Indústria Farmacêutica Ltda: Competitive Position 2008

EMS SA - OTC HEALTHCARE - BRAZIL

STRATEGIC DIRECTION

KEY FACTS

Summary 17 EMS SA: Key Facts

Summary 18 EMS SA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 19 EMS SA: Production Statistics 2007

COMPETITIVE POSITIONING

Summary 20 EMS SA: Competitive Position 2008

EUROFARMA LABORATóRIO LTDA - OTC HEALTHCARE - BRAZIL

STRATEGIC DIRECTION

KEY FACTS

Summary 21 Eurofarma Laboratório Ltda: Key Facts

Summary 22 Eurofarma Laboratório Ltda: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 23 Eurofarma Laboratório Ltda: Production Statistics 2007

COMPETITIVE POSITIONING

Summary 24 Eurofarma Laboratório Ltda: Competitive Position 2008

JANSSEN-CILAG FARMACEUTICA LTDA - OTC HEALTHCARE - BRAZIL

STRATEGIC DIRECTION

KEY FACTS

Summary 25 Janssen-Cilag Farmacêutica Ltda: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 26 Janssen-Cilag Farmacêutica Ltda: Competitive Position 2008

MEDLEY SA INDúSTRIA FARMACêUTICA - OTC HEALTHCARE - BRAZIL

STRATEGIC DIRECTION

KEY FACTS

Summary 27 Medley SA Indústria Farmacêutica: Key Facts

Summary 28 Medley SA Indústria Farmacêutica: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 29 Medley SA Indústria Farmacêutica: Production Statistics 2007

COMPETITIVE POSITIONING

Summary 30 Medley SA Indústria Farmacêutica: Competitive Position 2008

NYCOMED PHARMA LTDA - OTC HEALTHCARE - BRAZIL

STRATEGIC DIRECTION

KEY FACTS

Summary 31 Nycomed Pharma Ltda: Key Facts

Summary 32 Nycomed Pharma Ltda: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 33 Nycomed Pharma Ltda: Production Statistics 2007

COMPETITIVE POSITIONING

Summary 34 Nycomed Pharma Ltda: Competitive Position 2008

SANOFI-AVENTIS FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL

STRATEGIC DIRECTION

KEY FACTS

Summary 35 Sanofi-Aventis Farmacêutica Ltda: Key Facts

Summary 36 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 37 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2008

DIGESTIVE REMEDIES IN BRAZIL

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 11 Sales of Digestive Remedies by Subsector: Value 2003-2008

Table 12 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008

Table 13 Herbal vs Standard Digestive Remedies 2003-2008

Table 14 Digestive Remedies Company Shares by Value 2004-2008

Table 15 Digestive Remedies Brand Shares by Value 2005-2008

Table 16 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013

Table 17 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013

Change currency displayed
all prices excluding P&P
request more information

Available formats

  • Instant online access
  • Download PDF
  • Download Word document
research methodology

Get Acrobat Reader

click here to download Adobe Acrobat Reader 7.0

© Euromonitor International 2009